CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,032,584
- in 16 filings, $9.5M under 10b5-1 plans
Net −$17,032,584. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-11 | JEFFS ROGER Chief Executive Officer | Grant or award 10b5-1 | +229,327 | 1,041,520 | ||
| 2025-01-11 | JEFFS ROGER Chief Executive Officer | Grant or award · Performance Stock Units 10b5-1 | +229,327 | 229,327 | ||
| 2024-12-02 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −546 | $11.51 | $6K | 154,127 |
| 2024-12-02 | Kaseta Michael CFO and COO | Sale 10b5-1 | −1,091 | $11.51 | $13K | 312,328 |
| 2024-12-02 | Schundler Russell General Counsel | Sale 10b5-1 | −1,063 | $11.51 | $12K | 487,328 |
| 2024-12-02 | Adair Jason Chief Business Officer | Sale 10b5-1 | −455 | $11.51 | $5K | 119,223 |
| 2024-11-30 | Moomaw Scott Chief Commercial Officer | Exercise or conversion 10b5-1 | +1,875 | 154,673 | ||
| 2024-11-30 | Moomaw Scott Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,875 | 9,375 | ||
| 2024-11-30 | Kaseta Michael CFO and COO | Exercise or conversion 10b5-1 | +2,343 | 313,419 | ||
| 2024-11-30 | Kaseta Michael CFO and COO | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,343 | 11,719 | ||
| 2024-11-30 | Schundler Russell General Counsel | Exercise or conversion 10b5-1 | +2,343 | 488,391 | ||
| 2024-11-30 | Schundler Russell General Counsel | Exercise or conversion · Restricted Stock Unit 10b5-1 | −2,343 | 11,719 | ||
| 2024-11-30 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +1,563 | 119,678 | ||
| 2024-11-30 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,563 | 7,812 | ||
| 2024-10-28 | Adair Jason Chief Business Officer | Sale 10b5-1 | −459 | $11.31 | $5K | 118,115 |
| 2024-10-28 | Adair Jason Chief Business Officer | Sale 10b5-1 | +459 | $11.31 | $5K | 118,115 |
| 2024-10-18 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −2,526 | $11.19 | $28K | 204,857 |
| 2024-10-14 | Schundler Russell General Counsel | Sale 10b5-1 | −2,576 | $11.11 | $29K | 486,048 |
| 2024-10-14 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −2,260 | $11.11 | $25K | 207,383 |
Page 29 of 29 · 579 trades